Patient-Focused Guidance Writing: FDA Aiming For 'Sweet Spot' In Advice

US FDA’s first guidance on patient data collection methods will be ready by June, and agency wants to get the tone right from the start; agency assures stakeholders it will be “flexible” on accepting new tools.